Your browser doesn't support javascript.
loading
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma.
Powles, Thomas; Motzer, Robert J; Escudier, Bernard; Pal, Sumanta; Kollmannsberger, Christian; Pikiel, Joanna; Gurney, Howard; Rha, Sun Young; Park, Se Hoon; Geertsen, Poul F; Gross-Goupil, Marine; Grande, Enrique; Suarez, Cristina; Markby, David W; Arroyo, Alan; Dean, Mark; Choueiri, Toni K; George, Daniel.
Affiliation
  • Powles T; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust, Queen Mary, University of London, London, E1 4NS, UK. thomas.powles@bartsandthelondon.nhs.uk.
  • Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Escudier B; Gustave Roussy, 94 805, Villejuif Cedex, France.
  • Pal S; City of Hope National Medical Center, Duarte, CA, 91010, USA.
  • Kollmannsberger C; British Columbia Cancer Agency, BCCA Vancouver Cancer Centre, Vancouver, BC, V5Z 4E6, Canada.
  • Pikiel J; Wojewodzkie Centrum Onkologii, 80-219, Gdansk, Poland.
  • Gurney H; Macquarie University and Westmead Hospital, Macquarie University, Sydney, NSW, 2109, Australia.
  • Rha SY; Severance Hospital, Yonsei Cancer Center, Seodaemun-Gu, Seoul, 03722, South Korea.
  • Park SH; Samsung Medical Center, Seoul, South Korea.
  • Geertsen PF; Herlev and Gentofte Hospital, Herlev Hospital, Copenhagen University, Herlev, Denmark.
  • Gross-Goupil M; Groupe Hospitalier Saint André, 33000, Bordeaux, France.
  • Grande E; Hospital Universitario Ramón y Cajal, Ctra. Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
  • Suarez C; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
  • Markby DW; Exelixis, Inc, South San Francisco, CA, 94080, USA.
  • Arroyo A; Exelixis, Inc, South San Francisco, CA, 94080, USA.
  • Dean M; Exelixis, Inc, South San Francisco, CA, 94080, USA.
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • George D; Duke University Medical Center, Durham, NC, 27710, USA.
Br J Cancer ; 119(6): 663-669, 2018 09.
Article in En | MEDLINE | ID: mdl-30197417
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Everolimus / Kidney Neoplasms / Anilides Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Everolimus / Kidney Neoplasms / Anilides Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom